1. Lin, Huiran, Chen, Huitong, Lin, Ao, Yuan, Li, Zhuo, Zhenjian. 2021. Associations between LMO1 gene polymorphisms and central nervous system tumor susceptibility. In Pediatric investigation, 5, 281-287. doi:10.1002/ped4.12286. https://pubmed.ncbi.nlm.nih.gov/34938970/
2. Liu, Guo-Chang, Zhuo, Zhen-Jian, Zhu, Shi-Bo, Wang, Feng-Hua, Fu, Wen. 2017. Associations between LMO1 gene polymorphisms and Wilms' tumor susceptibility. In Oncotarget, 8, 50665-50672. doi:10.18632/oncotarget.16926. https://pubmed.ncbi.nlm.nih.gov/28881592/
3. He, Lili, Zhu, Jinhong, Han, Fei, He, Jing, Wu, Haiyan. 2018. LMO1 Gene Polymorphisms Reduce Neuroblastoma Risk in Eastern Chinese Children: A Three-Center Case-Control Study. In Frontiers in oncology, 8, 468. doi:10.3389/fonc.2018.00468. https://pubmed.ncbi.nlm.nih.gov/30406033/
4. He, Jing, Zhong, Wei, Zeng, Jixiao, Zou, Yan, Xia, Huimin. . LMO1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese population. In Oncotarget, 7, 22770-8. doi:10.18632/oncotarget.8178. https://pubmed.ncbi.nlm.nih.gov/27009839/
5. Gao, Lei, Wu, Jia, Wang, Hai, Peng, Yuping, Li, Yaomin. 2022. LMO1 Plays an Oncogenic Role in Human Glioma Associated With NF-kB Pathway. In Frontiers in oncology, 12, 770299. doi:10.3389/fonc.2022.770299. https://pubmed.ncbi.nlm.nih.gov/35280742/
6. Liu, Junguang, Yan, Peiyun, Jing, Niancai, Yang, Jili. 2014. LMO1 is a novel oncogene in colorectal cancer and its overexpression is a new predictive marker for anti-EGFR therapy. In Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 35, 8161-7. doi:10.1007/s13277-014-2066-y. https://pubmed.ncbi.nlm.nih.gov/24845030/
智鼠故事 
